There were 101 (89.3%) tumours arising from a distinct cell lineage (either PIT1, SF1 or TPIT) with tumours of SF1 lineage forming the larger group (39.8%) followed closely by PIT1 lineage (37.1%) and TPIT (12.4%). This evidence concerns the gene TBX19 and neoplasm.